{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:05:27Z","timestamp":1787663127622,"version":"build-2736575974"},"reference-count":70,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","so-online.net","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.suronc.2016.05.030","type":"journal-article","created":{"date-parts":[[2016,6,4]],"date-time":"2016-06-04T19:14:17Z","timestamp":1465067657000},"page":"298-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The influence of chemotherapy-associated sinusoidal dilatation on short-term outcome after partial hepatectomy for colorectal liver metastases: A systematic review with meta-analysis"],"prefix":"10.1016","volume":"25","author":[{"given":"Kim M.C.","family":"van Mierlo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos","family":"Kleijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander S.","family":"Rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank G.","family":"Schaap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis H.C.","family":"Dejong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven W.M.","family":"Olde Damink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.suronc.2016.05.030_bib1","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","article-title":"Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer","volume":"15","author":"Rubbia-Brandt","year":"2004","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.suronc.2016.05.030_bib2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2559.2010.03511.x","article-title":"Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis","volume":"56","author":"Rubbia-Brandt","year":"2010","journal-title":"Histopathology"},{"issue":"13","key":"10.1016\/j.suronc.2016.05.030_bib3","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1245\/s10434-012-2438-8","article-title":"Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis","volume":"19","author":"Robinson","year":"2012","journal-title":"Ann. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.suronc.2016.05.030_bib4","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1245\/s10434-011-2061-0","article-title":"A\u00a0systematic review of clinical response and survival outcomes of downsizing systemic chemotherapy and rescue liver surgery in patients with initially unresectable colorectal liver metastases","volume":"19","author":"Lam","year":"2012","journal-title":"Ann. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.suronc.2016.05.030_bib5","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/annonc\/mdi154","article-title":"Oxaliplatin combined with irinotecan and 5-fluorouracil\/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study","volume":"16","author":"Seium","year":"2005","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.suronc.2016.05.030_bib6","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/01.sla.0000141198.92114.f6","article-title":"Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival","volume":"240","author":"Adam","year":"2004","journal-title":"Ann. Surg."},{"issue":"4","key":"10.1016\/j.suronc.2016.05.030_bib7","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jhep.2011.10.023","article-title":"Identification of molecular pathways involved in oxaliplatin-associated sinusoidal dilatation","volume":"56","author":"Agostini","year":"2012","journal-title":"J.\u00a0Hepatol."},{"issue":"10","key":"10.1016\/j.suronc.2016.05.030_bib8","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/liv.12420","article-title":"Soluble thrombomodulin attenuates sinusoidal obstruction syndrome in rat through suppression of high mobility group box 1","volume":"34","author":"Nakamura","year":"2014","journal-title":"Liver Int."},{"issue":"2","key":"10.1016\/j.suronc.2016.05.030_bib9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jhep.2013.04.014","article-title":"Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model","volume":"59","author":"Robinson","year":"2013","journal-title":"J.\u00a0Hepatol."},{"issue":"2","key":"10.1016\/j.suronc.2016.05.030_bib10","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/hep.510310224","article-title":"Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat","volume":"31","author":"Wang","year":"2000","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.suronc.2016.05.030_bib11","doi-asserted-by":"crossref","first-page":"G1045","DOI":"10.1152\/ajpgi.00526.2002","article-title":"Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome","volume":"284","author":"DeLeve","year":"2003","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.suronc.2016.05.030_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jso.23046","article-title":"The flavonoid monoHER prevents monocrotaline-induced hepatic sinusoidal injury in rats","volume":"106","author":"Ezzat","year":"2012","journal-title":"J.\u00a0Surg. Oncol."},{"issue":"4","key":"10.1016\/j.suronc.2016.05.030_bib13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jceh.2014.10.002","article-title":"Sinusoidal obstruction syndrome (hepatic veno-occlusive disease)","volume":"4","author":"Fan","year":"2014","journal-title":"J.\u00a0Clin. Exp. Hepatol."},{"issue":"6","key":"10.1016\/j.suronc.2016.05.030_bib14","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.510290615","article-title":"Characterization of a reproducible rat model of hepatic veno-occlusive disease","volume":"29","author":"DeLeve","year":"1999","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.suronc.2016.05.030_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/bjs.6436","article-title":"Dangerous halo after neoadjuvant chemotherapy and two-step hepatectomy for colorectal liver metastases","volume":"96","author":"Mentha","year":"2009","journal-title":"Br. J. Surg."},{"issue":"15","key":"10.1016\/j.suronc.2016.05.030_bib16","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1200\/JCO.2009.27.5701","article-title":"Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury","volume":"28","author":"Overman","year":"2010","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"11","key":"10.1016\/j.suronc.2016.05.030_bib17","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0399-8320(06)73542-4","article-title":"Severe sinusoidal lesions: a serious and overlooked complication of oxaliplatin-containing chemotherapy?","volume":"30","author":"Arotcarena","year":"2006","journal-title":"Gastroenterol. Clin. Biol."},{"issue":"4","key":"10.1016\/j.suronc.2016.05.030_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3816\/CCC.2009.n.038","article-title":"Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injury","volume":"8","author":"Slade","year":"2009","journal-title":"Clin. Colorectal Cancer"},{"issue":"5","key":"10.1016\/j.suronc.2016.05.030_bib19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ejso.2013.12.009","article-title":"Splenic volume may be a useful indicator of the protective effect of bevacizumab against oxaliplatin-induced hepatic sinusoidal obstruction syndrome","volume":"40","author":"Imai","year":"2014","journal-title":"Eur. J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2016.05.030_bib20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SLA.0b013e31815774de","article-title":"Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy","volume":"247","author":"Nakano","year":"2008","journal-title":"Ann. Surg."},{"issue":"2","key":"10.1016\/j.suronc.2016.05.030_bib21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1245\/s10434-010-1317-4","article-title":"Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy","volume":"18","author":"Tamandl","year":"2011","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.suronc.2016.05.030_bib22","first-page":"404","article-title":"Influence of pre-surgical chemotherapy on liver parenchyma and post-surgical outcome of patients subjected to hepatectomy due to colorectal carcinoma metastases","volume":"88","author":"Gomez-Ramirez","year":"2010","journal-title":"Cir. Esp."},{"issue":"10","key":"10.1016\/j.suronc.2016.05.030_bib23","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1245\/s10434-010-1074-4","article-title":"Recovery of liver function after the cessation of preoperative chemotherapy for colorectal liver metastasis","volume":"17","author":"Takamoto","year":"2010","journal-title":"Ann. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.suronc.2016.05.030_bib24","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.ejso.2008.01.001","article-title":"Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases","volume":"34","author":"Kandutsch","year":"2008","journal-title":"Eur. J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2016.05.030_bib25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10147-010-0046-9","article-title":"Histological liver injury and surgical outcome after FOLFOX followed by a hepatectomy for colorectal liver metastases in Japanese patients","volume":"15","author":"Komori","year":"2010","journal-title":"Int. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2016.05.030_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11605-010-1368-7","article-title":"Chemotherapy, liver injury, and postoperative complications in colorectal liver metastases","volume":"15","author":"Makowiec","year":"2011","journal-title":"J.\u00a0Gastrointest. Surg."},{"issue":"7","key":"10.1016\/j.suronc.2016.05.030_bib27","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s11605-007-0149-4","article-title":"Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome","volume":"11","author":"Pawlik","year":"2007","journal-title":"J.\u00a0Gastrointest. Surg."},{"issue":"1","key":"10.1016\/j.suronc.2016.05.030_bib28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jso.20632","article-title":"Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes","volume":"95","author":"Sahajpal","year":"2007","journal-title":"J.\u00a0Surg. Oncol."},{"key":"10.1016\/j.suronc.2016.05.030_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1477-7819-11-65","article-title":"Effect of preoperative chemotherapy on postoperative liver regeneration following hepatic resection as estimated by liver volume","volume":"11","author":"Takeda","year":"2013","journal-title":"World J. Surg. Oncol."},{"issue":"Issue 9","key":"10.1016\/j.suronc.2016.05.030_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011284","article-title":"Individual recovery expectations and prognosis of outcomes in non-specific low back pain: prognostic factor exemplar review (Protocol)","author":"Hayden","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.suronc.2016.05.030_bib31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann. Intern. Med."},{"issue":"15","key":"10.1016\/j.suronc.2016.05.030_bib32","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology - a proposal for reporting","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.suronc.2016.05.030_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00595-010-4414-x","article-title":"Sinusoidal obstruction syndrome compromises liver regeneration in patients undergoing two-stage hepatectomy with portal vein embolization","volume":"41","author":"Narita","year":"2011","journal-title":"Surg. Today"},{"key":"10.1016\/j.suronc.2016.05.030_bib34","series-title":"CADTH Peer Review Checklist for Search Strategies","author":"CADTH, Canadian Agency for Drugs and Technologies in Health","year":"2013"},{"issue":"2","key":"10.1016\/j.suronc.2016.05.030_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann. Surg."},{"issue":"6","key":"10.1016\/j.suronc.2016.05.030_bib36","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/01.sla.0000189131.90876.9e","article-title":"The \u201c50-50 criteria\u201d on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy","volume":"242","author":"Balzan","year":"2005","journal-title":"Ann. Surg."},{"issue":"5","key":"10.1016\/j.suronc.2016.05.030_bib37","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jamcollsurg.2006.12.032","article-title":"Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy","volume":"204","author":"Mullen","year":"2007","journal-title":"J.\u00a0Am. Coll. Surg."},{"issue":"5","key":"10.1016\/j.suronc.2016.05.030_bib38","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.surg.2010.10.001","article-title":"Posthepatectomy liver failure: a definition and grading by the international study group of liver surgery (ISGLS)","volume":"149","author":"Rahbari","year":"2011","journal-title":"Surgery"},{"issue":"8","key":"10.1016\/j.suronc.2016.05.030_bib39","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/bjs.7503","article-title":"Development of a composite endpoint for randomized controlled trials in liver surgery","volume":"98","author":"van den Broek","year":"2011","journal-title":"Br. J. Surg."},{"issue":"6","key":"10.1016\/j.suronc.2016.05.030_bib40","doi-asserted-by":"crossref","first-page":"427","DOI":"10.7326\/0003-4819-144-6-200603210-00010","article-title":"Evaluation of the quality of prognosis studies in systematic reviews","volume":"144","author":"Hayden","year":"2006","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.suronc.2016.05.030_bib41","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.suronc.2016.05.030_bib42","doi-asserted-by":"crossref","first-page":"E44","DOI":"10.1503\/cjs.006413","article-title":"Prognostic factors for morbidity and mortality in elderly patients undergoing acute gastrointestinal surgery: a systematic review","volume":"57","author":"Davis","year":"2014","journal-title":"Can. J. Surg."},{"issue":"5","key":"10.1016\/j.suronc.2016.05.030_bib43","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00428-007-0497-1","article-title":"The pathological response to neoadjuvant chemotherapy with FOLFOX-4 for colorectal liver metastases: a comparative study","volume":"451","author":"Aloysius","year":"2007","journal-title":"Virchows Arch."},{"issue":"4","key":"10.1016\/j.suronc.2016.05.030_bib44","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.surg.2008.12.002","article-title":"Risk factors for chemotherapy-associated liver injuries: a multivariate analysis of a group of 146 patients with colorectal metastases","volume":"145","author":"Brouquet","year":"2009","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.suronc.2016.05.030_bib45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.surg.2009.01.004","article-title":"Prevalence and clinical relevance of pathological hepatic changes occurring after neoadjuvant chemotherapy for colorectal liver metastases","volume":"147","author":"Hubert","year":"2010","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.suronc.2016.05.030_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.sla.0000193603.26265.c3","article-title":"Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases","volume":"243","author":"Karoui","year":"2006","journal-title":"Ann. Surg."},{"issue":"11","key":"10.1016\/j.suronc.2016.05.030_bib47","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1245\/s10434-010-1166-1","article-title":"Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases","volume":"17","author":"Kishi","year":"2010","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2016.05.030_bib48","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10147-010-0176-0","article-title":"Splenomegaly in FOLFOX-naive stage IV or recurrent colorectal cancer patients due to chemotherapy-associated hepatotoxicity can be predicted by the aspartate aminotransferase to platelet ratio before chemotherapy","volume":"16","author":"Miura","year":"2011","journal-title":"Int. J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.suronc.2016.05.030_bib49","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1245\/s10434-012-2274-x","article-title":"What is a safe future liver remnant size in patients undergoing major hepatectomy for colorectal liver metastases and treated by intensive preoperative chemotherapy?","volume":"19","author":"Narita","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.suronc.2016.05.030_bib50","doi-asserted-by":"crossref","first-page":"314868","DOI":"10.1155\/2013\/314868","article-title":"A\u00a0reappraisal of chemotherapy-induced liver injury in colorectal liver metastases before the era of antiangiogenics","volume":"2013","author":"Nguyen-Khac","year":"2013","journal-title":"Int. J. Hepatol."},{"issue":"11","key":"10.1016\/j.suronc.2016.05.030_bib51","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1007\/s00268-010-0731-x","article-title":"Histological and immediate postoperative outcome after preoperative cetuximab: case-matched control study","volume":"34","author":"Pessaux","year":"2010","journal-title":"World J. Surg."},{"issue":"6","key":"10.1016\/j.suronc.2016.05.030_bib52","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ejso.2010.04.010","article-title":"Targeted molecular therapies (cetuximab and bevacizumab) do not induce additional hepatotoxicity: preliminary results of a case-control study","volume":"36","author":"Pessaux","year":"2010","journal-title":"Eur. J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2016.05.030_bib53","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/SLA.0b013e3181c79403","article-title":"Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome","volume":"251","author":"Soubrane","year":"2010","journal-title":"Ann. Surg."},{"issue":"7","key":"10.1016\/j.suronc.2016.05.030_bib54","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/jso.23142","article-title":"Effect of bevacizumab added preoperatively to oxaliplatin on liver injury and complications after resection of colorectal liver metastases","volume":"106","author":"van der Pool","year":"2012","journal-title":"J.\u00a0Surg. Oncol."},{"issue":"13","key":"10.1016\/j.suronc.2016.05.030_bib55","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases","volume":"24","author":"Vauthey","year":"2006","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"12","key":"10.1016\/j.suronc.2016.05.030_bib56","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/archsurg.2012.1867","article-title":"Prospective evaluation of accuracy of liver biopsy findings in the identification of chemotherapy-associated liver injuries","volume":"147","author":"Vigano","year":"2012","journal-title":"Arch. Surg."},{"issue":"1","key":"10.1016\/j.suronc.2016.05.030_bib57","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jamcollsurg.2012.08.030","article-title":"Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience","volume":"216","author":"Wolf","year":"2013","journal-title":"J.\u00a0Am. Coll. Surg."},{"key":"10.1016\/j.suronc.2016.05.030_bib58","doi-asserted-by":"crossref","first-page":"h870","DOI":"10.1136\/bmj.h870","article-title":"Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients","volume":"350","author":"Iorio","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.suronc.2016.05.030_bib59","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/2046-4053-2-71","article-title":"Judging the quality of evidence in reviews of prognostic factor research: adapting the GRADE framework","volume":"2","author":"Huguet","year":"2013","journal-title":"Syst. Rev."},{"issue":"7","key":"10.1016\/j.suronc.2016.05.030_bib60","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ejso.2015.03.223","article-title":"Histological response, pattern of tumor destruction and clinical outcome after neoadjuvant chemotherapy including bevacizumab or cetuximab in patients undergoing liver resection for colorectal liver metastases","volume":"41","author":"Stremitzer","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"issue":"12","key":"10.1016\/j.suronc.2016.05.030_bib61","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/cncr.23099","article-title":"Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases","volume":"110","author":"Ribero","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.suronc.2016.05.030_bib62","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/CMAR.S77400","article-title":"Cancer therapy and cardiovascular risk: focus on bevacizumab","volume":"7","author":"Economopoulou","year":"2015","journal-title":"Cancer Manag. Res."},{"issue":"9","key":"10.1016\/j.suronc.2016.05.030_bib63","doi-asserted-by":"crossref","first-page":"H1453","DOI":"10.1152\/ajpheart.00554.2015","article-title":"Drug-induced mitochondrial dysfunction and cardiotoxicity","volume":"309","author":"Varga","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.suronc.2016.05.030_bib64","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1245\/s10434-009-0447-z","article-title":"Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab","volume":"16","author":"Aussilhou","year":"2009","journal-title":"Ann. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.suronc.2016.05.030_bib65","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1200\/JCO.2007.13.7679","article-title":"Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer","volume":"26","author":"Gruenberger","year":"2008","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"13","key":"10.1016\/j.suronc.2016.05.030_bib66","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/bjs.9299","article-title":"Vascular reconstruction combined with liver resection for malignant tumours","volume":"100","author":"Dejong","year":"2013","journal-title":"Br. J. Surg."},{"issue":"12","key":"10.1016\/j.suronc.2016.05.030_bib67","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1245\/s10434-007-9522-5","article-title":"Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis","volume":"14","author":"Reddy","year":"2007","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2016.05.030_bib68","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00270-012-0440-y","article-title":"Portal vein embolization before liver resection: a systematic review","volume":"36","author":"van Lienden","year":"2013","journal-title":"Cardiovasc. Interv. Radiol."},{"issue":"5","key":"10.1016\/j.suronc.2016.05.030_bib69","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1067\/msy.2000.105294","article-title":"Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations","volume":"127","author":"Vauthey","year":"2000","journal-title":"Surgery"},{"key":"10.1016\/j.suronc.2016.05.030_bib70","doi-asserted-by":"crossref","first-page":"c221","DOI":"10.1136\/bmj.c221","article-title":"Meta-analysis of individual participant data: rationale, conduct, and reporting","volume":"340","author":"Riley","year":"2010","journal-title":"BMJ"}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0960740416300494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0960740416300494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T22:46:23Z","timestamp":1656629183000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740416300494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0960740416300494"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2016.05.030","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The influence of chemotherapy-associated sinusoidal dilatation on short-term outcome after partial hepatectomy for colorectal liver metastases: A systematic review with meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.suronc.2016.05.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}